What is the appropriate treatment for a patient with a positive Lyme screen and negative Immunoglobulin G (IgG) and Immunoglobulin M (IgM) results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Positive Lyme Screen with Negative IgG and IgM Results

A positive Lyme screen with negative IgG and IgM Western blot results does not indicate active Lyme disease and does not require antibiotic treatment. 1

Understanding Two-Tiered Testing Results

The CDC recommends a two-tiered testing approach for Lyme disease diagnosis:

  1. First-tier screening test: ELISA or indirect fluorescent antibody test
  2. Second-tier confirmatory test: Western blot for IgG and IgM antibodies

When interpreting these results:

  • A positive first-tier test requires confirmation with Western blot
  • For IgM Western blot to be positive: ≥2 of 3 specific bands (21-24,39, and 41 kDa) must be present
  • For IgG Western blot to be positive: ≥5 of 10 specific bands must be present 2

Clinical Decision Making

In this case:

  • The screening test is positive
  • Both IgG and IgM Western blots are negative
  • This pattern represents a false-positive screening test 1

Key Points:

  • Isolated positive screening tests without Western blot confirmation have poor specificity
  • Cross-reactions with other bacterial antigens are common 3
  • Overinterpreting a small number of antibody bands or a positive screening test alone leads to reduced specificity and potential misdiagnosis 2

Recommended Approach

  1. Do not initiate antibiotic therapy based on a positive screening test with negative Western blot results 1

  2. Reassess clinical presentation:

    • If erythema migrans rash is present in an endemic area, treat empirically regardless of serology 1
    • If no characteristic symptoms are present, consider alternative diagnoses
  3. Consider follow-up testing only if:

    • Symptoms consistent with early Lyme disease develop
    • There is a known recent tick exposure with symptoms
    • Testing was performed very early (within first 1-2 weeks of infection) 2

Common Pitfalls to Avoid

  • Overtreatment: Administering antibiotics based solely on positive screening tests leads to unnecessary antibiotic use and potential side effects 1

  • Misinterpretation: Positive screening with negative confirmatory testing is not diagnostic of Lyme disease 2, 3

  • Repeated testing: Without clinical changes, repeated testing increases the likelihood of false-positive results 1

  • Extended antibiotic courses: Not supported by evidence and may lead to adverse effects 1

Special Considerations

  • If clinical suspicion remains high despite negative serology, consider whether:
    • Testing was performed too early in the disease course
    • The patient has an erythema migrans rash in an endemic area (which allows clinical diagnosis)
    • Alternative diagnoses might explain the symptoms 1

Remember that serology as a single diagnostic tool has limited value and should only be used to support clinically suspected cases 3. The presence of nonspecific symptoms with a positive screening test but negative Western blot does not constitute evidence of active Lyme infection.

References

Guideline

Diagnosis and Treatment of Lyme Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.